We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio The use of a transcatheter mitral valve ...

First Report Investigation at TCT Published in JACC Shows Substantial Mitral Valve Regurgitation Reductions and Versatility of Dual-Stent Design "These early outcomes with the Intrepid TMVR System are ...

Medtronic plc (NYSE: MDT) announced early data for its self-expanding Intrepid transcatheter mitral valve replacement (TMVR) system for mitral valve regurgitation (MR) utilizing the transfemoral ...

DUBLIN, Sept. 27, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced it has received U.S. Food and Drug Administration (FDA) approval to begin an early feasibility study (EFS) for its ...

Medtronic's experimental new mitral valve has been implanted in the first of 1,200 patients in a clinical trial to test the device on people who could benefit from heart surgery for a condition called ...

DUBLIN and ORLANDO, Fla., Nov. 6, 2021 /CNW/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today presented early data for its self-expanding Intrepid ™ transcatheter mitral ...

Half Moon Medical's Technology Now Ready for Evaluation in Early Feasibility Study Half Moon recently received U.S. FDA approval of an early feasibility study in patients with severe, symptomatic ...

DUBLIN, Sept. 9, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in structural heart therapies, today announced U.S. Food and Drug Administration (FDA) approval of an early feasibility ...

It remains early days for transcatheter mitral-valve replacement (TMVR) as a minimally invasive way to treat severe, mitral regurgitation (MR), but it's even earlier days for TMVR as an endovascular ...

Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of ...